Fig 1.
Reported Cryptosporidium cases in Israel and incidence rate 2001–2018.
Fig 2.
Diagnosis and molecular genotyping.
Fig 3.
Cryptosporidium cases in Haifa and West Galilee per month during 2015.
Fig 4.
Age distribution of Cryptosporidium cases in Haifa and West Galilee during 2015.
Fig 5.
The geographic distribution and genotypes of Cryptosporidium cases in Israel.
A. Residence of the 2015 outbreak patients (N = 146), ploted on Haifa and West Galilee geographic map. B. Residence of genotyped patients. Purple, identyfied at the HMO but not genotyped; Red, C. hominis IeA11G3T3; Green, C. hominis IbA6G3. Grey, C. hominis IdA16; Light Blue, C. hominis IbA10G2; Yellow, C. parvum IIdA20G; Orange, C. parvum IIaA15G2R1. Maps were generated using Microreact [31]; A dynamic version that includes the tested determinants can be found at Microreact https://microreact.org/project/1hgtRJKlg/4da49c44 and https://microreact.org/project/HD3sxQKDh/350ce02e for Fig 5A and Fig 5B, respectively.
Table 1.
Cryptosporidium subtypes.
Fig 6.
Cryptosporidium cases per month in Haifa and West Galilee HMO 2003–2018.
The number of cases per month in the years 2003–2018 are shown (national database).